The article discusses an important advance for the development of sunless tanning strategies. Effectiveness of salt-inducible kinase (SIK2) inhibitors as melanocyte-targeted and safety in modulating melanin levels in the epidermis, is highlighted. An overview on the investigation of SIK2 function to non-melanocyte cells in epidermis, also emphasized.